PDUFA decision for Reata’s (RETA) Friedreich’s ataxia drug
$RETA Probability Sentiment SUMMARY The inherited neuromuscular disorder Friedreich’s ataxia (FA) strikes early and harshly. [...]
$RETA Probability Sentiment SUMMARY The inherited neuromuscular disorder Friedreich’s ataxia (FA) strikes early and harshly. [...]
Prometheus Biosciences, Inc. (NASDAQ:RXDX) Probability Sentiment SUMMARY Early-stage investors continue to back new drugs for [...]
$RANI Probability Sentiment Needles. Who enjoys needles? No one. If someone claims indifference to regular [...]
Apellis Pharmaceuticals (NASDAQ:APLS) on June 1 submitted an NDA for its drug pegcetacoplan to be approved to treat geographic atrophy [...]
uniqure N.v. (NASDAQ:QURE) Probability Sentiment SUMMARY The inherited bleeding disorder hemophilia remains a lucrative rare [...]
Travere Therapeutics, Inc. (NASDAQ:TVTX) Probability Sentiment SUMMARY Travere Therapeutics’ (NASDAQ:TVTX) received a PDUFA decision date [...]
Adicet Bio, Inc. (NASDAQ:ACET) Probability Sentiment SUMMARY While first-generation, autologous chimeric antigen receptor (CAR) T [...]
Insmed, Inc. (NASDAQ:INSM) Probability Sentiment SUMMARY Pulmonary arterial hypertension (PAH) comprises a group of severe [...]